Evidence map›Paper›PMID 8108408›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1994

Dual promoter activation by the human beta-globin locus control region.

E H Bresnick, G Felsenfeld

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Synergism between hypersensitive sites confers long-range gene activation by the beta-globin locus control region.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
  5. Article
  6. Long-range disruption of gene expression by a selectable marker cassette.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

E H BresnickNational Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Laboratory of Molecular Biology, Bethesda, MD 20892.
G Felsenfeld
National Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human beta-globin locus control region (LCR) is necessary for high-level and position-independent expression of globin genes in erythroid cells. A variety of mechanisms have been proposed for the cis-activation of individual members of the beta-globin gene family by the LCR located 10-50 kilobases upstream. It is not known, however, whether a given LCR can activate all developmentally appropriate globin family members on its chromosome or whether, within a given chromosome, the LCR must be committed to activating only a single gene. We have devised an experiment to distinguish between these possibilities. This experiment takes advantage of the fact that if two genes in a cluster are transcriptionally active and their promoters, therefore, are in a conformation hypersensitive to nucleases, restriction enzymes that cleave the promoters will excise the intervening chromatin fragment. The Apa I sites on human fetal G gamma- and A gamma-globin gene promoters are accessible to cleavage in nuclei from the human erythroleukemia cell line K562, which expresses these genes, but not in HeLa cells. We find that Apa I digestion leads to excision in high yield of the fragment spanning these promoters, showing that a LCR element is capable of sharing its activating function among members of a gene cluster on a single chromosome.

Indexed as

Gene Expression RegulationCells, CulturedChromatinChromosomes, HumanDeoxyribonucleases, Type II Site-SpecificDNA, NeoplasmGlobinsHeLa CellsHumansLeukemia, Erythroblastic, AcutePromoter Regions, GeneticRegulatory Sequences, Nucleic AcidChromatinDeoxyribonucleases, Type II Site-SpecificDNA, NeoplasmGGGCCC-specific type II deoxyribonucleasesGlobins

Identifiers

PMID8108408
PMCPMC43148
OpenAlexW2077497566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.